Perorally active nanomicellar formulation of quercetin in the treatment of lung cancer - Test2 - elhamkhani - TriplyDB

Perorally active nanomicellar formulation of quercetin in the treatment of lung cancer

Perorally active nanomicellar formulation of quercetin in the treatment of lung cancer

http://www.wikidata.org/entity/Q35753059

about

Advanced Nanobiomaterials: Vaccines, Diagnosis and Treatment of Infectious Diseases Mitochondrion: A Promising Target for Nanoparticle-Based Vaccine Delivery Systems.From Antigen Delivery System to Adjuvanticy: The Board Application of Nanoparticles in Vaccinology Immunological properties of gold nanoparticles High sensitive detection of carbohydrate binding proteins in an ELISA-solid phase assay based on multivalent glyconanoparticles.Enhancing the anti-colon cancer activity of quercetin by self-assembled micelles.Multivalent glycoconjugates as anti-pathogenic agents Preparation and immunogenicity of gold glyco-nanoparticles as antipneumococcal vaccine model.Novel nanoparticle vaccines for Listeriosis.Development and characterization of self-assembling lecithin-based mixed polymeric micelles containing quercetin in cancer treatment and an in vivo pharmacokinetic study.Dietary flavonoid intake and the risk of digestive tract cancers: a systematic review and meta-analysis.Clustered carbohydrates in synthetic vaccines.Pregnancy Vaccination with Gold Glyco-Nanoparticles Carrying Listeria monocytogenes Peptides Protects against Listeriosis and Brain- and Cutaneous-Associated Morbidities.Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals.Glyconanoparticles as multifunctional and multimodal carbohydrate systems.Glyconanotechnology.The effects of engineered nanoparticles on pulmonary immune homeostasis.Site-specific anticancer effects of dietary flavonoid quercetin.Therapeutic potential of carbohydrate-based polymeric and nanoparticle systems.Gold nanoparticles and vaccine development.Solid lipid nanoparticles as oral delivery systems of phenolic compounds: Overcoming pharmacokinetic limitations for nutraceutical applications.Applications of Gold Nanoparticles in Nanomedicine: Recent Advances in Vaccines.Design of nanomaterial based systems for novel vaccine development.Gold nanoparticles displaying tumor-associated self-antigens as a potential vaccine for cancer immunotherapy.Synthetically defined glycoprotein vaccines: current status and future directions.Mapping the Glyco-Gold Nanoparticles of Different Shapes Toxicity, Biodistribution and Sequestration in Adult Zebrafish.Electrically Oscillating Plasmonic Nanoparticles for Enhanced DNA Vaccination against Hepatitis C Virus.Pharmacokinetics and tissue distribution of amphotericin B following oral administration of three lipid-based formulations to rats.Molecular Mechanisms and Pathways as Targets for Cancer Prevention and Progression with Dietary Compounds.Phytochemical based nanomedicines against cancer: current status and future prospects.Gold glyconanoparticles coupled to listeriolysin O 91-99 peptide serve as adjuvant therapy against melanoma.Interactions between the antifungal drug myclobutanil and gold and silver nanoparticles in Penicillium digitatum investigated by surface-enhanced Raman scattering Synthesis of conjugation-ready zwitterionic oligosaccharides by chemoselective thioglycoside activation

P2860

Q26744748-3BC20DFC-055D-45AD-BBB2-99E9801C3C80 Q26748776-EFC4E305-82C0-47FA-92FE-45BE5BC89481 Q26778126-59BFF04D-38A8-417D-B282-E6BFF70E1649 Q33578950-79EDAB94-09B6-4F70-8736-40ABA329E66C Q34981074-4357AC6F-563A-4FDE-9CA4-5572FCB5A1D9 Q35201530-76D22213-3C45-4422-9581-DED02CC7FA46 Q35444698-B15851BD-C164-47C9-87B9-3BE157C4B417 Q36202229-850ECA07-4801-4FB9-905F-B09A75E1CFFC Q36256378-41C8F660-360E-49DE-BCAB-AB322A8561D1 Q36826807-125BCF4C-5836-4894-838D-6FDBAB853078 Q36835598-1B4446EB-7F9A-4037-896B-FF2012A42C52 Q36844110-1789EF31-998C-41A8-87C6-2CAC361ECDC5 Q37577596-9C10AD88-FA71-40DF-9BEB-0B7C42CF58A7 Q37646827-5445FF1A-D7A4-46B0-AFFF-B9C916704A40 Q38071545-F272973D-CCCD-431E-B7B0-7CAFFFCD6931 Q38072859-BF5A05E2-19FA-4B75-933C-EF8E5E50D978 Q38165210-C10A5A23-11E5-407A-812D-BAB46621F354 Q38174655-621D5D9F-820C-45FC-9562-4A080A1B44C1 Q38199152-5E20C440-9DA4-4337-9051-FEB597E4D809 Q38543673-4DA6EC99-46F0-4966-89E5-6F4FE8D88C6B Q38550745-24F38CEC-D737-4BE3-8A26-38728B370843 Q38680785-02138B62-CE62-4110-AD7B-B50DB294AA27 Q38739675-3EBBC20B-E322-4E74-A2E4-E49BA8B7DD17 Q39013318-FDAE6063-1945-40F8-A4F0-FD9020B18571 Q39375701-C9C84ED5-5EE0-4913-9087-B9074CFB0C17 Q41042113-3A9F5D96-7BDE-4ED8-ABBD-C388AD9FECEF Q45324175-ACB79EED-035E-4D47-8B3D-5F7DD6555735 Q45850524-7AE23EB2-5D2C-4D3F-855F-1526CECDC0DF Q46300890-DAF355B0-2E11-4180-A449-7CF61464B417 Q47829215-DC2C8F1A-9376-468F-8AF0-E5E97700C03A Q53159624-6D8A92B1-529A-49C1-9C1C-4649C8BB9F8E Q57165079-66E8A3B5-2763-4C31-82D5-CDDE2B3E9407 Q57525962-6037A1CD-301F-455A-AAAA-9F6337BF945A

P2860

Perorally active nanomicellar formulation of quercetin in the treatment of lung cancer

http://www.wikidata.org/entity/Q35753059

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Perorally active nanomicellar formulation of quercetin in the treatment of lung cancer

@ast

Perorally active nanomicellar formulation of quercetin in the treatment of lung cancer

@en

type

label

Perorally active nanomicellar formulation of quercetin in the treatment of lung cancer

@ast

Perorally active nanomicellar formulation of quercetin in the treatment of lung cancer

@en

prefLabel

Perorally active nanomicellar formulation of quercetin in the treatment of lung cancer

@ast

Perorally active nanomicellar formulation of quercetin in the treatment of lung cancer

@en

P1433

Q35753059-2F9CB41F-A77B-413E-BDD4-46F97215772E

P1476

Q35753059-07139AAB-9719-4953-84E2-0F5EC699DD43

P2093

Q35753059-249E66CE-29E6-496B-BC45-4893619162B8

Q35753059-2CD90D74-D84D-4002-A949-3DF47107FF60

Q35753059-57E21A5C-9BCE-4D30-8287-18D27E2B884B

Q35753059-894F0121-B664-45DA-9F70-FD0D1E6FF86F

Q35753059-AB5889AA-B9C0-48ED-9468-7FF233B4A8CC

P2860

Q35753059-017695B6-0941-4196-9A38-2EDD72CF86B7

Q35753059-06EFE20C-EACB-433B-8A61-74C42E64A46D

Q35753059-07968B64-C9A1-4D09-9B59-DE169EE41AEC

Q35753059-124881C1-C567-40C8-B30A-A7C8DD625392

Q35753059-20A5039C-B98C-43DA-B505-167B51DD4D65

Q35753059-237B53FB-DC80-4522-962D-EC4CBFF1F9BD

Q35753059-31E12B42-EFB4-4513-8653-542019A30BFD

Q35753059-353FE95F-068E-4033-8190-15265B5AF7B0

Q35753059-36010E87-4183-4811-8978-5A0BA860B24E

Q35753059-3917AF61-5E5A-4161-A59A-84BBA66FBBBC

P304

Q35753059-6607C854-4A06-4AF0-8FB2-1F53E5115E0C

P31

Q35753059-41C7D536-BF98-4EB4-B3CE-C7422A3E31F4

P356

Q35753059-81E6702E-E8BD-4E1B-9FCA-573FEE86C86B

P407

Q35753059-DB6949E8-75E3-42F9-89A9-5324B0EADB2E

P478

Q35753059-FC180F15-33AE-4411-B2DA-0AE445283CD3

P577

Q35753059-7BC1E1C5-033B-4F7D-82C3-CF61F41DE6CD

P5875

Q35753059-986EE2B7-9829-47FA-832E-15656015F10C

P698

Q35753059-34b09b15-5d23-4c07-9ca6-4549e84c4ce6

Q35753059-43581546-DD3A-4399-8799-09D31DA3D99B

P932

Q35753059-5F4E95D2-6C41-4016-AC0F-451A29DE4A94

P356

P1433

International Journal of Nanomedicine

P1476

Perorally active nanomicellar formulation of quercetin in the treatment of lung cancer

@en

P2093

Bee-Jen Tan

http://www.w3.org/2001/XMLSchema#string

Bennie K W Lim

http://www.w3.org/2001/XMLSchema#string

Gigi N C Chiu

http://www.w3.org/2001/XMLSchema#string

Kai-Lun Chang

http://www.w3.org/2001/XMLSchema#string

Yuanjie Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies

Drug-like properties and the causes of poor solubility and poor permeability.

Gold glyconanoparticles: synthetic polyvalent ligands mimicking glycocalyx-like surfaces as tools for glycobiological studies.

Targeting the carbohydrates on HIV-1: Interaction of oligomannose dendrons with human monoclonal antibody 2G12 and DC-SIGN

Interleukin-17A mediates acquired immunity to pneumococcal colonization

Gold manno-glyconanoparticles: multivalent systems to block HIV-1 gp120 binding to the lectin DC-SIGN.

Robust immune responses elicited by a fully synthetic three-component vaccine.

P304

651-661

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/NNM.11.151

http://www.w3.org/2001/XMLSchema#string

P407

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2012-02-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225061565

http://www.w3.org/2001/XMLSchema#string

P698

22334787

http://www.w3.org/2001/XMLSchema#string

P932

3278229

http://www.w3.org/2001/XMLSchema#string